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14SA ﬁrst-in-man study of the role of ﬂexible robotics
in overcoming navigation challenges in the
iliofemoral arteries
Jean Bismuth, MD,a Cassidy Duran, MD,a Milenko Stankovic, MD,b Borut Gersak, MD,b and
Alan B. Lumsden, MD,a Houston, Tex; and Ljubljana, Slovenia
Objective: Current interventional techniques rely heavily on operator familiarity with catheters and wires and on physician
skills in effectively navigating through and managing target lesions. A novel robotic technology allows endovascular
specialists to remotely control catheter tip deﬂection and advancement and to coordinate manipulation of currently
available wires. The aim of this study was to successfully demonstrate feasibility and safety of navigation to and treatment
of iliac and femoral artery lesions using Hansen Medical’s vascular control catheter (VCC).
Methods: A total of 20 limbs were included in this analysis for a ﬁrst-in-man trial of the VCC and vascular catheter control
system. The local Institutional Review Board approved the trial, and all patients included had symptomatic femo-
ropopliteal occlusive disease. Preoperative imaging was available on all patients. Target lesions in the contralateral
superﬁcial femoral artery ranged from mild stenosis to chronic total occlusions (TransAtlantic Inter-Society A through
D). Exclusion criteria included previously treated iliac and femoral lesions in the symptomatic leg and a body mass index
>35. The operators comprised three experienced interventionalists (two vascular surgeons and an interventional radiol-
ogist) and a novice (cardiac surgeon). The primary end point of the study was to demonstrate successful cannulation of
the target vessel (ie, navigation to the lesion with wire and catheter) with the Hansen VCC, with no device-related serious
adverse events. Secondary end points were to assess the ability to treat lesions using the ﬂexible catheter deﬁned by
successful insertion of a guidewire, angiography of the target vessel, delivery of balloon, and/or stent. Procedure times
and radiation delivered were analyzed for the group and by operator, and t-test was performed to determine statistical
signiﬁcance. Complications were assessed by clinical examination and ultrasound.
Results: Lesions were successfully and safely cannulated in all limbs treated. The VCC performed as designed in all cases.
All interventionalists, regardless of experience, navigated the VCC with ease. However, statistically signiﬁcant differences
in navigation time and radiation per case were observed between the experienced and inexperienced interventionalists.
There were no access site complications (hematoma, thrombosis, pseudoaneurysm) as evaluated by ultrasound.
Conclusions: This initial experience in ﬂexible robotics demonstrates that this technology is both efﬁcacious and safe in the
arterial tree. Although robotics provides superior maneuverability compared with current techniques, endovascular
experience is crucial to taking full advantage of the extra capabilities. Valuable future considerations will include off-the-
wall (center lumen) navigation with three-dimensional imaging. (J Vasc Surg 2013;57:14S-9S.)The gold standard for treatment of symptomatic
peripheral artery disease (PAD) is open surgical bypass.1
However, PAD is known to be a marker for disease in other
vascular beds, and these patients are often poor operative
candidates who beneﬁt from less invasive endovascular
approaches to managing their disease. The lesions caused
by PAD are often complex, chronic, and tortuous, making
them difﬁcult to access using currently available manualThe Methodist Hospital, Methodist DeBakey Heart & Vascular
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from vessel injury and embolic events.
Flexible robotics. Surgical assistance systems provide
intelligent, versatile tools that have enabled surgeons to
treat otherwise untreatable conditions, all while reducing
morbidity and error rates, shortening operative times,
reducing radiation exposure, and improving overall work-
ﬂow.2 These capabilities have recently begun to be real-
ized in vascular surgery through ﬂexible robotics for
exclusion of complex aortic aneurysms using branched
endografts, as well as in other applications such as
pulmonary artery stenting.3-6
Diagnostic and interventional catheters are currently
limited by their ability to simply rotate around a single
axis. The interventionalist depends on a variety of pre-
formed catheters to ﬁt nonuniform vascular anatomy.
Therefore, single catheters are often inadequate to perform
complex interventions, and interventionalists are forced to
use a multitude of catheters to get to the site of the
intended intervention. Having a catheter with which move-
ment is controlled in multiple planes allows for greater
precision, conﬁdence, and safety as the surgeon proceeds
Table I. Patient demographics
Variable Average 6 SD Data range
Age 69 6 10 years 45-84 years
BMI 28 6 4 23-34
Sex Males by subject Males by procedure
12, (80%) 17, (85%)
Fontaine classiﬁcation
Stage I 1
Stage IIa 3
Stage IIb 14
Stage III 3
Stage IV 2
BMI, Body mass index; SD, standard deviation.
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surgery provides such a catheter, enabling ﬁne, predictable,
and consistent movements, ultimately increasing procedural
speed and reliability.
Hansen Medical (Mountain View, Calif) is a lead devel-
oper of advanced medical robotics and robotic technology
for endovascular interventions with proprietary technolo-
gies for peripheral vascular interventions. Development of
endovascular robotic technology at Hansen Medical was
initiated by engineers with robotic experience with Intuitive
Surgical’s (Sunnyvale, Calif) daVinci robot. In 2007, they
received FDA approval for their Sensei robotic system for
use in cardiac ablation procedures, and at that time, vascular
surgeons began investigating the utility of endovascular
robotics to assist in cannulation of aortic branch vessels,
and an initial description of a gate cannulation for an
endovascular aneurysm repair was described.2 Nonclinical
investigation of the system demonstrated clear beneﬁts in
cannulation times, tool movements, accuracy, radiation
times, and performance scores over conventional methods
in complex endovascular procedures performed on silicone
aortic models.3
Electrophysiologists have also shown decreased radia-
tion times for ablation cases. 7 Riga and colleagues demon-
strated the technical feasibility of robot-assisted antegrade
in situ fenestrated stent grafting in pigs using the Artisan
catheter, Hansen Medical’s ﬁrst-generation endovascular
catheter system, and 4 in our own institution, we have
shown its utility in the treatment of pulmonary artery
stenoses in a transplant patient.6
However, the Artisan catheter has notable limitations
in practical utility for peripheral interventions, and as such,
Hansen developed the vascular catheter. Early work has
again shown improvement in the learning curve, improved
cannulation times, and decreased vessel injury in a porcine
model compared with manual control.8,9
This is the ﬁrst human study using a catheter speciﬁ-
cally designed for this purpose. The primary aim of the
study was to demonstrate successful cannulation of the
target vessel with Hansen Medical’s vascular control
catheter (VCC), with no device-related serious adverse
events. Secondary end points were to assess the ability
to treat lesions using the ﬂexible catheter deﬁned by
successful insertion of a guidewire, angiography of the
target vessel, delivery of balloon, and/or stent. We addi-
tionally sought to address questions of setup, installation
and preparation, durability of the robot, evaluate perfor-
mance based on differing skill levels among intervention-
alists, and assess catheter performance in different phases
of the procedure.
METHODS
In this prospective, single-arm study, we sought to vali-
date in humans the improved outcomes observed in our
preliminary animal trials. Three of the four operators partici-
pating in the study had signiﬁcant experience (>500 cases)
with performing endovascular interventions (operators 1, 3,
and 4). Procedure times and radiation delivered wereanalyzed for the group and by operator, and t-test was per-
formed to determine statistical signiﬁcance.
Patients involved in the study were previously diag-
nosed with iliac or femoral atherosclerotic disease requiring
therapeutic intervention and were consented for inclusion
in the study. Twelve male subjects and three female
subjects (age, 68 6 10 years) were scheduled for endovas-
cular intervention and were treated using the Hansen
Medical vascular catheter control system (VCSC) and
vascular control catheter VCC (Table I). Five male subjects
were scheduled for bilateral treatment separated by a
minimum of 48 hours from their primary treatment. Inclu-
sion criteria were age >18 years, symptomatic disease, pres-
ence of critical limb ischemia (including tissue loss or rest
pain) or lifestyle-limiting claudication, presence of superﬁ-
cial femoral artery or iliac stenosis (>50%) or occlusion of
up to 30 cm in length, and life expectancy of at least 1
year. Patients were excluded if the target vessel had been
previously treated with bypass or stenting, showed evi-
dence of previous dissection or perforation, adjacent acute
thrombus was noted, or if the lesion was highly calciﬁed. In
addition, subjects who had a contraindication to anticoagu-
lation, bleeding or a hypercoagulability disorder, thrombo-
cytopenia, elevated international normalized ratio (>1.5),
elevated serum creatinine ($ 2.5 mg/dL), active infection,
or contraindication to contrast were also excluded.
Patients were diagnosed with mild to severe claudica-
tion and exhibited anatomic variability ranging from insig-
niﬁcant to severe tortuosity of the iliac arteries and
aortailiac bifurcation. Target lesions in the contralateral
superﬁcial femoral artery ranged from mild stenoses to
chronic total occlusions. Interventions involved lesions
from the common iliac to the proximal popliteal arteries
on the contralateral side.
Device description. The Hansen vascular catheter
control system (VCCS) is the next generation of Hansen
Medical’s development of ﬂexible catheter robotics. The
system technology is based on the Sensei robotic sys-
tem and Artisan control catheter, which are marketed
in the United States, the European Union, and other
countries of the world for use in the electrophysiology
ﬁeld.
Fig 1. Comparison of the Artisan catheter with the Hansen
vascular catheter.
Fig 2. Inner leader catheter moving relative to outer guiding
sheath.
JOURNAL OF VASCULAR SURGERY
16S Bismuth et al February Supplement 2013The Hansen VCC (Fig 1) is smaller in diameter than
the Artisan catheter (9F outer diameter, which accommo-
dates 6F third-party devices) and has greater articulation
capabilities with steerable inner and outer guidable catheter
enabling 6 degrees of freedom and further enhances tactile
and visual depiction of issue deformation. The telescoping
design is based on an inner leader catheter that moves
relative to an outer guiding sheath (Fig 2). The leader cath-
eter and the guiding sheath each have four pull wires
creating ﬁxed-length, independent bending sections at
the distal section of each of the catheters. The pull wires,
embedded into the catheter wall architecture, control the
articulating segments of the leader catheter and guiding
sheath. This allows for robotic control of articulation in
four directions. The catheters have a conventional thin-
walled composite design of plastic extrusion and metal
braid laminated together to form a catheter wall. They
are disposable and intended for single use only. The
guiding sheath has an outer diameter consistent with
a 7F manual sheath and an inner diameter consistent
with a 6F manual sheath and is capable of accommodating
6F compatible devices. The leader catheter ﬁts inside the
outer sheath and has a 0.039-inch guidewire lumen that
facilitates delivery and control of guidewires up to 0.035-
inch diameter. The study catheters were for investigational
use only and labeled accordingly.
The VCC is controlled by the Hansen Medical VCCS.
The VCCS is based on a master/slave control system that
enables positioning of the VCC tip at a desired position in
the vasculature by a physician seated away from x-ray radi-
ation. The VCCS’s operating principles are similar to those
of the Sensei System. However, the VCCS contains addi-
tional hardware and software integration that allows the
user to control the additional bending segments of the
VCC and the guidewire control module and robotic Set
Up Joint.
The sheath is manually inserted through the common
femoral artery access, which was obtained by ultrasoundguidance. The proximal end of the sheath is attached, via
the splayer interface, to a remote catheter manipulator
(RCM), which is positioned above the patient’s leg. The
RCM provides the mechanisms for selective actuation of
the catheter pull wires and for the insertion axes of the tele-
scoping catheters. The VCC interfaces with the RCM via
the same mechanism as the existing Artisan control cath-
eter. The mechanisms by which the VCCS RCM articulates
the distal ends of the VCC are the same as those used in the
Sensei RCM. The physician sits at a workstation console
equipped with a pendant interface, which, for the ﬁrst-in-
man trial, was a button-driven interface. The physician
inputs motion commands to the pendant to control the
motion of the VCC and guidewire. The VCCS translates
the pendant inputs into actuation of the catheter via the
RCM and motion of the guidewire via the guidewire
manipulator. In addition to the pendant, the console also
includes a screen displaying commanded catheter and
wire position and orientation, ﬂuoroscopic imaging, and
patient information. An electronics rack, which can be
placed up to 100 feet from the RCM, contains the
computers, power supplies, and video distribution compo-
nents of the system (Fig 3). The VCCS was labeled for
investigational use only for this study.
Table II. Procedure times
Period
Time, minutes
(average 6 SD)
Time, minutes
(minimum/
maximum)
Preprocedure VCCS
preparation time
13 6 4 7/21
Preprocedure VCC
preparation time
2 6 2 1/8
Navigation time
(VCC initialized to
wire across lesion)a
21 6 11 10/46
Total VCC time
(includes manual
treatment through
sheath)
67 6 28 31/119
Total procedure time 82 6 31 43/143
Fluoroscopy
Timeb 27 6 14 15/71
Dose (Gy)b .000621 6 .000360 178.3/1523.3
SD, Standard deviation; VCC, vascular control catheter; VCCS, vascular
catheter control system.
aDoes not include the one procedure for which the wire did not re-enter the
true lumen.
bAnalysis includes the procedure for which the wire did not re-enter the true
lumen.
Fig 3. Intraoperative photograph of remote catheter manipulator
and vascular control catheter system.
Fig 4. TransAtlantic Inter-Society (TASC) classiﬁcation of lesions
navigated and treated.
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From September 20 through 28, 2010, 15 consecutive
patients with 20 lesions (age, 45-84 years) with symptoms
of claudication, weak (10 limbs) or absent (10 limbs)
peripheral pulses, abnormal ankle-brachial indices (16/
20; range, 0.346-1.25), and conﬁrmation of iliofemoral
and femoropopliteal lesions demonstrated by preoperative
computed tomography angiography (16) or magnetic reso-
nance imaging (four) were treated. Of the vessels treated or
navigated, all aortoiliac lesions were TransAtlantic Inter-Society (TASC) A and B, whereas the femoropopliteal
lesions were predominantly TASC B (Fig 4). Tortuosity
of the vessels was also graded (severe ¼ tortuosity in the
common iliac and external iliac, moderate ¼ tortuosity in
either common iliac segment or external and mild/none)
and was found to be most commonly mild to moderate.
We were 100% successful in our primary goal of access-
ing the lesion, in that we were able to navigate safely to the
target femoropopliteal lesion identiﬁed preoperatively.
Nineteen of the 20 limbs were successfully treated with
balloon angioplasty and stents were placed in 10 out of
20. In total, 12 iliac, 24 femoral, and ﬁve popliteal lesions
were treated. There were no adverse events or periproce-
dural complications identiﬁed. Ultrasound was performed
within 24 hours of each procedure, and there were no
complications imaged at the access site. One patient had
a postprocedure hematoma after the operator failed to
hold pressure after decannulating the vessel. However,
follow-up ultrasound showed no evidence of persistent
hematoma or pseudoaneurysm.
Operators were also able to cross from the access point
to the contralateral side, over the aortic bifurcation, with
0.018-inch wires, a maneuver that typically requires the
use of a 0.035-inch stiff wire when advancing a sheath.
There were no technical complications with the VCCS or
the catheters and no catheter breakdown or malfunction
that would necessitate use of an additional catheter.
Furthermore, there were no complications or malfunction-
ing of the VCCS throughout the study period.
Procedure times averaged 82 6 30 minutes, and the
mean duration of navigation with the Hansen VCCS was
21 6 10 minutes. Total ﬂuoroscopy time 26 6 14 minutes
and dose 621 6 .00036 Gy (Tables II and III).
Table III. Procedure times by operator
By operator time (minutes) average 6 SD
Period OR1 (n ¼ 7) OR2 (n ¼ 7) OR3 (n ¼ 5) P value OR4 (n ¼ 1)
Total preparation timea 14 6 5 12 6 3 12 6 4 - 11.0
Navigation time (VCC initialized to
wire across lesion)b
21 6 10 24 6 13 19 6 10 .3466 13
Total VCC time (includes manual
treatment through sheath)
61 6 26 82 6 32 60 6 21 .005 31
Total procedure time 78 6 30 97 6 33 75 6 22 .08 44
Fluoroscopy
Time 23.3 6 8.7 35.4 6 19.0 22 6 10 .03 15
Dose (Gy)c .000473 6 .000223 .000666 6 .000321 .000613 6 .000535 - .00029
OR, Operator; SD, standard deviation; VCC, vascular control catheter.
OR1 and OR3 (experienced interventionalist); OR2 (novice interventionalist). P value ¼ evaluates difference between OR 1-3 (OR 4 not part of calculation as
he only performed one case).
aThe operator did not participate in preparation of the system.
bDoes not include the one procedure for which the wire did not re-enter the true lumen.
cAnalysis includes the procedure for which the wire did not re-enter the true lumen.
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The primary and secondary aims for this study were
met for all but one of the lesions, in which the operator
with the least experience was unable to successfully cross
the lesion. All four operators were otherwise able to cross
all other lesions, including operator 2, who had no previous
endovascular experience. Navigation times, VCC times,
and total ﬂuoroscopy times were longer for the inexperi-
enced operator. Times were comparable for the operators
with the most experience. There was no trend toward
improvement in procedure times, which is likely secondary
to the small number of cases. In the setting of electrophys-
iology, Valderrábano previously demonstrated (in unpub-
lished data) that there is a signiﬁcant learning curve in
using the Artisan catheter, with the operator requiring 20
to 30 cases prior to achieving proﬁciency. Riga et al
concluded that robotic catheters appear to be more intui-
tive than standard techniques and that advanced skills
acquisition occurs with minimal training.9 We believe
that this is probably misleading, as our experience shows
that there is more to navigation than just getting to the
target. The interventionalist’s experience is of utmost
importance, as unlike the anatomy of silicone models, vessel
pathology can vary signiﬁcantly, and so navigation is less
predictable. These variations are critical in inﬂuencing navi-
gation and treatment. It is an understanding of vessel inter-
actions and treatment modalities that will dictate outcomes,
and although robotics does improve maneuverability, it
does not eliminate the need for experience. Therefore, the
experienced interventionalist is most likely going to be
able to take greatest advantage of the addedmaneuverability
for advanced procedures, while the novice will have
a learning curve, which we believe is mostly based on an
understanding of basic endovascular therapeutics.
Bannazadeh et al demonstrated that as the complexity
of the procedure increased, so did the impact of radia-
tion.10 Their conclusion was that future innovations shouldconcentrate on reducing the risk of radiation exposure and
developing newer imaging techniques. Flexible robotics are
very much a step in this direction, and so we believe this is
likely a place where ﬂexible robotics stand to have great
impact. We are unable to comment on the effect of remote
navigation on radiation exposure to the operator in the
current study, as dosimeters were not used for the trial.
This represents a limitation of the study. However, given
that the operator’s position remote from the radiation
source is limited only by operating room size, it stands
to reason that the radiation dose would be signiﬁcantly
reduced in this setting.
CONCLUSIONS
The Hansen Medical Vascular Catheter Control
System was used to safely and successfully navigate 20 of
20 lesions with tortuosity ranging from simple to complex
and able to treat 19 of 20 lesions from the common iliac
artery to the below-the-knee section of the popliteal artery.
In this early experience, endovascular procedures using
remote robotic catheter navigation were feasible, safe,
effective, and associated with positive physician feedback
regarding ease of use for navigation of tortuous and/or
difﬁcult anatomies.
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